Published in Am J Med on August 01, 1975
SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis. J Clin Invest (1988) 1.90
Pseudorejection: factors mimicking rejection in renal allograft recipients. Ann Surg (1977) 1.13
The pathology of renal homograft rejection. A review. Am J Pathol (1976) 0.89
Living-related donor transplants should be performed with caution in patients with focal segmental glomerulosclerosis. Pediatr Nephrol (1995) 0.84
Infiltration of Macrophages Correlates with Severity of Allograft Rejection and Outcome in Human Kidney Transplantation. PLoS One (2016) 0.76
Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet (1994) 3.73
Pathogenesis of the renal lesion associated with the abuse of analgesics. Lancet (1967) 3.70
Papillary necrosis in rats caused by aspirin and aspirin-containing mixtures. Br Med J (1970) 3.46
Anticoagulants in "irreversible" acute renal failure. Lancet (1968) 2.24
Cutaneous necrosis from calcific uremic arteriolopathy. Am J Kidney Dis (1998) 2.18
The association of peptic ulceration, chronic renal disease, and analgesic abuse. Q J Med (1966) 2.07
Papillary necrosis in experimental analgesic nephropathy. Br Med J (1969) 2.07
A new look at the treatment of severe hypertension. Clin Sci Mol Med Suppl (1973) 1.96
Detection of glomerular bleeding by phase-contrast microscopy. Lancet (1982) 1.85
Histological diagnosis of rejection of renal homografts in man. Lancet (1967) 1.73
Dipyridamole and anticoagulants in renal disease due to glomerular and vascular lesions. A new approach to therapy. Med J Aust (1970) 1.71
Reflux nephropathy. Br Med J (Clin Res Ed) (1983) 1.70
The clinical course of mesangial IgA associated nephropathy in adults. Q J Med (1984) 1.63
Analgesic nephropathy. A common form of renal disease in Australia. Med J Aust (1969) 1.62
Coagulation and renal disease. Kidney Int (1972) 1.61
Controlled trial comparing effect of two and six weeks' treatment in recurrent urinary tract infection. Br Med J (1969) 1.55
Cyclophosphamide-induced ovarian failure. N Engl J Med (1973) 1.53
Cadaveric renal transplantation. Lancet (1967) 1.52
Analgesic nephropathy. Br Med J (1970) 1.51
Phenotype and genotype heterogeneity in autosomal dominant polycystic kidney disease. Lancet (1992) 1.47
The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial. Clin Nephrol (1990) 1.44
Lesions in the blood supply of the papilla in experimental analgesic nephropathy. Med J Aust (1968) 1.42
Pregnancy in women with primary focal and segmental hyalinosis and sclerosis. Clin Nephrol (1988) 1.39
Deterioration in renal function in association with co-trimoxazole therapy. Lancet (1973) 1.34
Prolonged use of methyldopa in severe hypertension in pregnancy. Br Med J (1966) 1.31
Haematuria and exercise-related haematuria. Br Med J (Clin Res Ed) (1982) 1.26
Cancer development in patients progressing to dialysis and renal transplantation. Transplant Proc (1985) 1.14
Scalp tingling in patients on labetalol. Lancet (1977) 1.14
Methyldopa and haemolytic anaemia. Med J Aust (1967) 1.13
Immediate renal-graft biopsy and subsequent rejection. Lancet (1968) 1.12
The antiviral activity of certain thiophosphate and 2'-chloro substituted polynucleotide homopolymer duplexes. Virology (1972) 1.10
Renal papillary necrosis with a normal pyelogram. Br Med J (1968) 1.09
Renal-biopsy findings in lithium and prelithium patients. Lancet (1979) 1.08
Clinical experience with the angiotensin converting enzyme inhibitor captopril. Clin Exp Pharmacol Physiol Suppl (1982) 1.08
Modification of the vascular lesions of rejection in cadaveric renal allografts by dipyridamole and anticoagulants. Lancet (1969) 1.08
Mesangiocapillary glomerulonephritis type II (dense-deposit disease): clinical features of progressive disease. Am J Kidney Dis (1989) 1.08
Lesions in the vasa recta in experimental analgesic nephropathy. Lancet (1968) 1.07
Cadaveric renal transplantation. Lancet (1968) 1.07
Uterine artery Doppler flow velocity waveforms in the second trimester for the prediction of preeclampsia and fetal growth retardation. Obstet Gynecol (1994) 1.07
"First dose" effect of captopril. Aust N Z J Med (1982) 1.07
Effects of non-narcotic analgesics on the kidney. Drugs (1986) 1.05
Long-term follow-up of renal function and histology after acute tubular necrosis. Ann Intern Med (1970) 1.03
Lupus nephritis: clinical and pathological correlation. Q J Med (1987) 1.02
The treatment of chronic mesangiocapillary (membranoproliferative) glomerulonephritis with impaired renal function. Med J Aust (1972) 1.02
Glomerular size and glomerulosclerosis in Australian aborigines. Am J Kidney Dis (2000) 1.01
Membranous glomerulonephritis and Landry-Guillain-Barre syndrome. Am J Kidney Dis (1986) 1.01
Repeated renal failure with use of captopril in a cystinotic renal allograft recipient. Br Med J (Clin Res Ed) (1982) 1.01
Diltiazem in renal allograft recipients receiving cyclosporine. Transplantation (1993) 1.01
Macroscopic hematuria in mesangial IgA nephropathy: correlation with glomerular crescents and renal dysfunction. Kidney Int (1983) 1.00
Renal artey stenosis in renal transplantation. Med J Aust (1971) 1.00
Mesangial IgA nephropathy. Am J Kidney Dis (1983) 0.98
Sickle cell disease and the kidney. Am J Kidney Dis (1993) 0.98
Goodpasture's syndrome: normal renal diagnostic findings. Ann Intern Med (1975) 0.97
Analgesic nephropathy. Ann Intern Med (1968) 0.97
Unique tubular lesion after lithium. Lancet (1978) 0.97
Specificity of elongation factor Tu from Escherichia coli with respect to attachment to the amino acid to the 2' or 3'-hydroxyl group of the terminal adenosine of tRNA. Eur J Biochem (1977) 0.96
De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transplant Proc (1993) 0.95
Early peri-operative glycaemic control and allograft rejection in patients with diabetes mellitus: a pilot study. Transplantation (2001) 0.95
Prospective leucocyte typing in cadaver renal transplantation. Lancet (1968) 0.94
Polymeric IgA and immune complex concentrations in IgA-related renal disease. Kidney Int (1990) 0.94
Diazoxide in the treatment of the acute hypertensive emergency. Med J Aust (1968) 0.94
Scanning electron microscopy of glomerular and non glomerular red blood cells. Clin Nephrol (1983) 0.93
Treatable complications in undiagnosed cases of autosomal dominant polycystic kidney disease. Lancet (1991) 0.93
Single-dose therapy in management of urinary tract infection. Med J Aust (1978) 0.93
Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood. Nucl Med Biol (2000) 0.91
Integrated programme of dialysis and renal transplantation. Results in 155 patients. Lancet (1975) 0.91
Treatment of IgA nephropathy with eicosapentanoic acid (EPA): a two-year prospective trial. Clin Nephrol (1989) 0.91
"Malignant" IgA nephropathy. Am J Kidney Dis (1985) 0.90
Diltiazem-cyclosporin pharmacokinetic interaction--dose-response relationship. Br J Clin Pharmacol (1997) 0.90
Membranous glomerulonephritis and pregnancy. Clin Nephrol (1987) 0.90
Analgesic nephropathy in perspective. Med J Aust (1967) 0.90
Reflux nephropathy: the glomerular lesion and progression of renal failure. Pediatr Nephrol (1993) 0.90
Quantitative counts in urine microscopy. Med J Aust (1979) 0.89
Goodpasture's syndrome in identical twins. Ann Intern Med (1978) 0.89
Dissecting aneurysm of the renal artery. Radiology (1970) 0.89
Single day or single dose treatment of urinary tract infection with Co-trimoxazole. Aust N Z J Med (1980) 0.89
Whole blood viscosity in preeclampsia. Am J Obstet Gynecol (1982) 0.89
Effect of pregnancy on moderate renal failure in reflux nephropathy. Br Med J (Clin Res Ed) (1986) 0.88
Morphologic evidence that analgesic-induced kidney pathology contributes to the progression of tumors of the renal pelvis. Cancer (1999) 0.88
The natural history and treatment of membranous glomerulonephritis. Perspect Nephrol Hypertens (1973) 0.88
Malignant hypertension: mechanisms and management. Pharmacol Ther (1980) 0.88
Renal insufficiency with combinations of angiotensin converting enzyme inhibitors and diuretics. Br Med J (Clin Res Ed) (1984) 0.88
Localisation of complement components in association with glomerular extracellular particles in various renal diseases. Virchows Arch A Pathol Anat Histopathol (1991) 0.88
Superimposed glomerular immune complexes in anti-glomerular basement membrane disease. Am J Kidney Dis (1989) 0.88
A comparison of the hyperuricaemic effect of chlorothiazide and quinethazone. Med J Aust (1967) 0.88
Early peri-operative hyperglycaemia and renal allograft rejection in patients without diabetes. BMC Nephrol (2000) 0.87
Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture's syndrome. Q J Med (1985) 0.87
Participation of intravascular coagulation in the pathogenesis of glomerular and vascular lesions. Kidney Int (1975) 0.87
Effect of renal transplantation on left ventricular function in hemodialysis patients. Clin Nephrol (1982) 0.87
Non-steroidal anti-inflammatory drugs and blood pressure. Aust N Z J Med (1982) 0.87